Alternative technologies in cervical cancer screening

Conditions

Cervical cancer Cancer Malignant neoplasm of cervix uteri

Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A, Laurila P, Tarkkanen J, Anttila A.

2012-11-2959 citations

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.

Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P.

2010-04-27102 citations

10.1136/bmj.c1804

Interventions

Alternative screening techniques (automation-assisted cytological screening, and HPV-DeoxyriboNucleic Acid [DNA] based screening) are compared to conventional cytological screening.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women invited to routine cervical cancer screening programme within municipalities contracted

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Subsequent cervical cancer incidence among women invited	—

Secondary

Measure	Time frame
1. Mortality from cervical cancers. 2. Detection and incidence of precancerous lesions	—

Countries

Finland

Outcome results

None listed